Tag: AbbVie
AbbVie would gain an experimental eczema drug by buying biotech: report MarketWatch Source link
Eczema is one of the main skin conditions that can develop over time. Also, if you sometimes have itchy and red spots on your hands, it’s probably eczema. Eczema is often called atopic dermatitis, where atopic refers to allergy. Also, any eczema may have persistent symptoms such as dry or scaly skin, redness or itching. […]
The Eczema Therapeutics Market research report presents a complete and concise global market study. It offers quantitative and qualitative information on the entire industry structure. This Eczema Therapeutics research report delivers an overview of the market based on the segmentation, which helps the client easily understand the need. The markets are expected to depict a […]
On Jan. 14, AbbVie‘s (NYSE:ABBV) Rinvoq received approval from the U.S. Food and Drug Administration (FDA) to treat adults and children at least 12 years old with moderate-to-severe atopic dermatitis (eczema) whose condition didn’t respond to other medicines. What led the FDA to approve Rinvoq for its third indication? And how much of a boost […]